Today: 29 April 2026
Browse Category

NASDAQ:DNLI 10 December 2025 - 29 January 2026

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
····
US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

Polestar Automotive shares dropped 25.1% Wednesday after a 1-for-30 reverse stock split and trading halt, with analysts citing ongoing losses and debt concerns. The S&P 500 and Dow hit new highs following a Fed rate cut, but several high-profile stocks, including AeroVironment and Denali Therapeutics, also posted double-digit declines. Microcaps like Work Medical Technology plunged over 85%.
10 December 2025
········
Top Pre‑Market Losers Today (December 10, 2025): AFJK, CBRL, DNLI & AEG Lead Early Declines Before the Bell

Top Pre‑Market Losers Today (December 10, 2025): AFJK, CBRL, DNLI & AEG Lead Early Declines Before the Bell

Aimei Health Technology plunged nearly 50% in pre-market trading after extending its business-combination deadline. Lion Group Holding and JX Luxventure Group each dropped over 35%. Broader U.S. stock futures showed little movement as investors awaited the Federal Reserve’s rate decision later today. Cracker Barrel and Denali Therapeutics also traded lower on fresh news and analyst calls.
10 December 2025
····

Stock Market Today

No summaries found on the roundup post.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop